Glycosyltransferase GLT8D1 and GLT8D2 have been reported to be associated with head and neck squamous cell carcinoma, melanomas, glioma, GBM, and ovarian cancer chemoresistance [14, 15, 18, 45, 46]. Here, GLT8D2 is linked to glioblastoma.